Haissam Chraiteh – President & Director General, Sanofi Morocco
16.04.2015
Related Interviews
Driss Chaoui – CEO, Afric-Phar, Morocco
Dr Driss Chaoui, CEO of Afric-Phar, one of the leading domestic companies in Moroccan pharma, provides insight into the major developments that have taken place at the company since we…
Sofia Lahlou – Country Manager, Versalya, Morocco
Sofia Lahlou, country manager for women’s and children’s health specialist Versalya in the Moroccan market, discusses the company’s formation, its therapeutic priorities, and the opportunities that exist for women in…
Fadela Benjelloun – Executive Director, LEMM, Morocco
Fadela Benjelloun, executive director of LEMM, the association of multinational pharma companies in Morocco, explains the association’s key goals of improving access to healthcare and medicines, positioning Morocco as an…
France / Owkin Becomes Unicorn; Sanofi/Baidu Tie-up for mRNA Algorithm; New Deals for Pierre Fabre & Abionyx
The latest news from French pharma, including AI-based biotech Owkin’s new status as a USD one billion-valued unicorn following fresh investment from Sanofi. Also included is another deal for Sanofi,…
APAC / 5 Management Tips from Life Science Leaders
The Asia-Pacific (APAC) region is home to around 1.44 billion people, over 60 percent of the world’s population, and a vast diversity of cultures, infrastructures, and economic development. Managing a…
Global / Sanofi Genzyme EVP Bill Sibold Reflects on 30 Years of Rare Disease CSR Program
Bill Sibold, Executive Vice President and Head of Sanofi Genzyme, highlights the achievements of the company’s Rare Humanitarian Program over the last 30 years, bringing treatments to patients in developing…
Latest Report
